Trial Profile
Silodosin 4mg versus tamsulosin 0.2mg once daily; randomized crossover study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jul 2015
Price :
$35
*
At a glance
- Drugs Silodosin (Primary) ; Tamsulosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 20 Jul 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 08 Feb 2011 New trial record